References
- Tyson MD, Humphreys MR, Parker AS, et al. Age-period-cohort analysis of renal cell carcinoma in United States adults. Urology. 2013;82:43–47.
- Chow WH, Devesa SS, Warren JL, et al. Rising incidence of renal cell cancer in the United States. JAMA. 1999;281:1628–1631.
- Hollingsworth JM, Miller DC, Daignault S, et al. Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst. 2006;98:1331–1334.
- Schieda N, Al-Subhi M, Flood TA, et al. Diagnostic accuracy of segmental enhancement inversion for the diagnosis of renal oncocytoma using biphasic computed tomography (CT) and multiphase contrast-enhanced magnetic resonance imaging (MRI). Eur Radiol. 2014;24:2787–2794.
- Woo S, Suh CH, Cho JY, et al. Diagnostic performance of CT for diagnosis of fat-poor angiomyolipoma in patients with renal masses: a systematic review and meta-analysis. AJR Am J Roentgenol 2017;209(5):W297–W307.
- Lindkvist Pedersen C, Winck-Flyvholm L, Dahl C, et al. High rate of benign histology in radiologically suspect renal lesions. Dan Med J. 2014;61:A4932.
- Ljungberg B, Cowan NC, Hanbury DC, et al. EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol. 2010;58:398–406.
- Marconi L, Dabestani S, Lam TB, et al. Systematic review and meta-analysis of diagnostic accuracy of percutaneous renal tumour biopsy. Eur Urol. 2016;69:660–673.
- Dindo D, Demartines N, Clavien P-A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–213.
- Wood BJ, Khan MA, McGovern F, et al. Imaging guided biopsy of renal masses: indications, accuracy and impact on clinical management. J Urol. 1999;161:1470–1474.
- Murphy WM, Zambroni BR, Emerson LD, et al. Aspiration biopsy of the kidney. Simultaneous collection of cytologic and histologic specimens. Cancer. 1985;56:200–205.
- Volpe A, Kachura JR, Geddie WR, et al. Techniques, safety and accuracy of sampling of renal tumors by fine needle aspiration and core biopsy. J Urol. 2007;178:379–386.
- Nisen H, Järvinen P, Fovaeus M, et al. Contemporary treatment of renal tumors: a questionnaire survey in the Nordic countries (the NORENCA-I study). Scand J Urol. 2017;51:360–366.
- Azawi NH, Tolouee SA, Madsen M, et al. Core needle biopsy clarify the histology of the small renal masses and may prevent overtreatment. Int Urol Nephrol. 2018;50:1205–1209.
- Remzi M, Marberger M. Renal tumor biopsies for evaluation of small renal tumors: why, in whom, and how?. Eur Urol. 2009;55:359–367.
- Leveridge MJ, Finelli A, Kachura JR, et al. Outcomes of small renal mass needle core biopsy, nondiagnostic percutaneous biopsy, and the role of repeat biopsy. Eur Urol. 2011;60:578–584.
- Whittier WL, Korbet SM. Timing of complications in percutaneous renal biopsy. J Am Soc Nephrol. 2004;15:142–147.
- Roccatello D, Sciascia S, Rossi D, et al. Outpatient percutaneous native renal biopsy: safety profile in a large monocentric cohort. BMJ Open. 2017;7:e015243.
- Beisland C, Johannesen TB, Reisaeter LAR, et al. Real-life use of diagnostic biopsies before treatment of kidney cancer: results from a Norwegian population-based study. Scand J Urol. 2018;52:38–44.